New cytostatics—more activity and less toxicity
- 30 September 1990
- journal article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 17 (2-3) , 143-154
- https://doi.org/10.1016/0305-7372(90)90039-i
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Characterization of the antitumor activity of hexadecylphosphocholine (D 18506)European Journal of Cancer and Clinical Oncology, 1988
- No relevant influence on overall survival time in patients with metastatic breast cancer undergoing combination chemotherapyZeitschrift für Krebsforschung und Klinische Onkologie, 1988
- New cytostatics with experimentally different toxic profilesCancer Treatment Reviews, 1987
- Is the P388 murine tumor no longer adequate as a drug discovery model?Investigational New Drugs, 1987
- Estrogen-linked 2-chloroethylnitrosoureas: Anticancer efficacy in MNU-induced rat mammary carcinoma, uterine activity in mice and receptor interactionsEuropean Journal of Cancer and Clinical Oncology, 1986
- Effectiveness of P-aminobenzyol-O-phenylenediamine (Goe 1734) against mouse, rat, and human tumour cellsCancer Chemotherapy and Pharmacology, 1985
- The inhibitory effect of 5-acetoxy-2-(4-acetoxyphenyl)-1-ethyl-3-methylindole (D 16726) on estrogen-dependent mammary tumorsEuropean Journal of Cancer and Clinical Oncology, 1985
- Do we need new chemosensitive experimental models?European Journal of Cancer and Clinical Oncology, 1984
- Influence of the Alkyllysophospholipid ET-18-OCH3 on Methylnitrosourea-induced Rat Mammary CarcinomasOncology, 1984
- Noncarcinogenic chemotherapy with a combination of vincristine, methotrexate and 5-fluorouracil (VMF) in ratsInternational Journal of Cancer, 1983